The Week

Cytokinetics' cardiac myosin inhibitor, Myqorzo, is the first to demonstrate significant, clinically meaningfu…

Roche's Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) desig…

It took Cytokinetics 27 years to win its first drug approval. With the results of a new trial, its second coul…

The US FDA is set to review Kowa Pharmaceuticals America's NDA for K-911, an investigational once-daily eye dr…

Though its data could be useful for pharmaceutical firms, Polansky's latest entrepreneurial endeavor, Outer Bi…

New leaders at GSK, Novo Nordisk and Sanofi are taking the reins at pivotal moments for three of pharma's larg…